These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37139652)

  • 21. Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options.
    Kaufmann GR; Cooper DA
    Curr Opin Microbiol; 2000 Oct; 3(5):508-14. PubMed ID: 11050451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New options for dosage of medications].
    Brus E
    Sidahora; 2003; (3):16-7. PubMed ID: 14971358
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
    Posit Aware; 2006; Spec No():17-22. PubMed ID: 16596730
    [No Abstract]   [Full Text] [Related]  

  • 24. [New treatment options for HIV-infected patients].
    Wehr A
    Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468
    [No Abstract]   [Full Text] [Related]  

  • 25. Preserving future therapeutic options: should we limit the lamivudine use in young HIV-1 infected children initiating first-line HAART?
    Frange P; Chaix ML; Blanche S
    AIDS; 2013 Jan; 27(2):151-4. PubMed ID: 23032408
    [No Abstract]   [Full Text] [Related]  

  • 26. 3rd IAS conference: new drugs and treatment of experienced patients.
    Lucas GM
    Hopkins HIV Rep; 2005 Sep; 17(5):4-5. PubMed ID: 16419301
    [No Abstract]   [Full Text] [Related]  

  • 27. Is HIV treatment HIV prevention?
    O'Neal R
    BETA; 2009; 21(4):30-6. PubMed ID: 20034244
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: Anti-infective 2020: HIV-From pathogenesis to treatment.
    Huerta L
    Curr Opin Pharmacol; 2020 Oct; 54():x-xii. PubMed ID: 33357716
    [No Abstract]   [Full Text] [Related]  

  • 29. [Follow-up of HIV-positive people with text messages].
    Brodwall K
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1602. PubMed ID: 23045730
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 31. Awareness. Black Americans unaware HIV treatment options available.
    AIDS Policy Law; 2003 Aug; 18(15):4. PubMed ID: 14974382
    [No Abstract]   [Full Text] [Related]  

  • 32. SPRING: a new trial to evaluate tipranavir in heterogeneous treatment-experienced HIV populations.
    Vispo E
    AIDS Rev; 2007; 9(2):126-7. PubMed ID: 17695065
    [No Abstract]   [Full Text] [Related]  

  • 33. [HIV infection 2007].
    Potthoff A; Brockmeyer N;
    Med Klin (Munich); 2007 Jul; 102(7):531-9. PubMed ID: 17634871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance and the treatment of experienced patients.
    Gallant JE
    Hopkins HIV Rep; 2002 Sep; 14(5):1, 5-7, 16. PubMed ID: 12240639
    [No Abstract]   [Full Text] [Related]  

  • 35. Adherence to HAART in HIV.
    Lazzarini L; Lanzafame M; Trevenzoli M; Vento S; Concia E
    Lancet; 1999 Mar; 353(9155):841. PubMed ID: 10459983
    [No Abstract]   [Full Text] [Related]  

  • 36. Approach to the treatment-experienced patient.
    Gallant JE
    Infect Dis Clin North Am; 2007 Mar; 21(1):85-102, viii-ix. PubMed ID: 17502231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uganda to treat more people infected with HIV with antiretrovirals.
    Wasswa H
    BMJ; 2008 Sep; 337():a1610. PubMed ID: 18784172
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical management of HIV drug resistance.
    Cortez KJ; Maldarelli F
    Viruses; 2011 Apr; 3(4):347-78. PubMed ID: 21994737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report from Los Angeles: the 14th Conference on Retroviruses and Opportunistic Infections (CROI). New data on treatment-experienced patients and drug resistance.
    Lucas GM
    Hopkins HIV Rep; 2007 Mar; 19(2):4-6. PubMed ID: 17882786
    [No Abstract]   [Full Text] [Related]  

  • 40. Emtricitabine compared with lamivudine may preserve future therapeutic options in HIV-1-infected children.
    Frange P; Blanche S; Chaix ML
    J Antimicrob Chemother; 2013 Nov; 68(11):2694-5. PubMed ID: 23743089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.